Interpretation of DXA Scans and VFA Deborah Sellmeyer, MD Director, - - PowerPoint PPT Presentation

interpretation of dxa scans and vfa
SMART_READER_LITE
LIVE PREVIEW

Interpretation of DXA Scans and VFA Deborah Sellmeyer, MD Director, - - PowerPoint PPT Presentation

Interpretation of DXA Scans and VFA Deborah Sellmeyer, MD Director, Johns Hopkins Metabolic Bone Center Dept of Medicine, Division of Endocrinology Page 1 DXA Technology Detector (detects 2 tissue types - bone and soft tissue) Very low


slide-1
SLIDE 1

Page 1

Interpretation of DXA Scans and VFA

Deborah Sellmeyer, MD Director, Johns Hopkins Metabolic Bone Center Dept of Medicine, Division of Endocrinology

slide-2
SLIDE 2

Page 2

DXA Technology

X-ray Source (two energies with different attenuation profiles) Collimator (pinhole for pencil beam, slit for

fan beam)

Patient Detector (detects 2 tissue types - bone and soft tissue)

Very low radiation to patient. Very little scatter radiation to technologist

slide-3
SLIDE 3

Page 3

Lumbar Spine Positioning

  • Straight spine
  • Equal soft tissue on

both sides of vertebra

  • Correct labeling
  • No artifacts
slide-4
SLIDE 4

Page 4

Hip Positioning

  • Femoral shaft vertical
  • Small amount lesser trochanter
  • Rotation decreases lesser trochanter and

apparent femoral neck BMD

  • No ischium in femoral neck ROI

Femoral Neck ROI different between Hologic and GE Lunar Lunar Hologic

slide-5
SLIDE 5

Page 5

DXA #1

Name, contact info for facility Name, contact info for facility

Patient Name Med Record number DOB Patient Name Med Record number DOB

Demo- graphics

Date Software Technologist Machine Measured directly Calculated = BMC (g) area (cm2)

T-score = SD’s above (+) or below (-) young reference population Z-score = SD’s above or below age matched reference population

Reference population

slide-6
SLIDE 6

Page 6

DXA #2

slide-7
SLIDE 7

Page 7

DXA #3

slide-8
SLIDE 8

Page 8

DXA #4

slide-9
SLIDE 9

Page 9

DXA #5

slide-10
SLIDE 10

Page 10

DXA #6

slide-11
SLIDE 11

Page 11

DXA #7

slide-12
SLIDE 12

Page 12

DXA #8

slide-13
SLIDE 13

Page 13

DXA #9

slide-14
SLIDE 14

Page 14

DXA #9

10 20 30 40 50 60 70 BONE MASS AGE 50% during adolescence

Using pediatric reference, Z-score = -0.1 http://www.bcm.edu/bodycomplab/mainbodycomp.htm

slide-15
SLIDE 15

Page 15

DXA #10

Lunar Hologic

slide-16
SLIDE 16

Page 16

DXA #11

Hologic Lunar

slide-17
SLIDE 17

Page 17

DXA #12

2017 2016

slide-18
SLIDE 18

Page 18

DXA #13

slide-19
SLIDE 19

Page 19

DXA #13

slide-20
SLIDE 20

Page 20

DXA #13

slide-21
SLIDE 21

Page 21

DXA #14

slide-22
SLIDE 22

Page 22

DXA #15

slide-23
SLIDE 23

Page 23

DXA #15

2017 2016

slide-24
SLIDE 24

Page 24

DXA #16

slide-25
SLIDE 25

Page 25

DXA #16

slide-26
SLIDE 26

Page 26

DXA #17

slide-27
SLIDE 27

Page 27

DXA #17

slide-28
SLIDE 28

Page 28

DXA #17

slide-29
SLIDE 29

Page 29

Radius styloid process excluded Ultradistal line where radius and ulna meet 1/3 forearm site determine by radius length Size of ROI box ROI should extend beyond soft tissue

slide-30
SLIDE 30

Page 30

2015 DXA #18 2014

slide-31
SLIDE 31

Page 31

DXA #19

slide-32
SLIDE 32

Page 32

DXA #19

slide-33
SLIDE 33

Page 33

DXA #20

slide-34
SLIDE 34

Page 34

Vertebral Fracture Assessment (VFA)

slide-35
SLIDE 35

Page 35

slide-36
SLIDE 36

Page 36

Grading Vertebral Deformities

Grade 1 Sensitivity = 52%-96% Grade 2 or higher Sensitivity = 96% Specificity = 90%

slide-37
SLIDE 37

Page 37

Indications for VFA

  • Women age 65-70 years and men age 70-80 years if T-score is
  • 1.5 or below.
  • Women age 70 years and men age 80 and older regardless of

T-score.

  • Postmenopausal women and men age 50 and older with a low

trauma fracture.

  • Postmenopausal women and men age 50-69 with:

– historical height loss of 1.5 inches or more – prospective height loss of 1.5 inches or more – recent or ongoing long-term glucocorticoid treatment.

  • F. Cosman, et. al. Osteoporos Int. 2015; 26(7): 2045–2047.
slide-38
SLIDE 38

Page 38

Questions?